Frontiers
US$ 25.92
oral glp-1 drugs for weight loss Orforglipron Is Approved Obesity Feel fuller Oral Wegovy Guide | Medical
Description
These medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
FEBS Lett (1987) 211(2):16974
Those who continued GLP-1 treatment for two or two-and-a-half years before discontinuing for the remainder of the study also gained significant risk reduction (7% and 15%, respectively)
Is there a drug interaction between GLP-1 RAs and SGLT2 inhibitors
Epub 2022 Aug 18
